Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

Addus HomeCare is a leading provider of in-home care services, with a strong presence in the personal care, hospice, and home health segments. The company's diversification across these segments and its large number of locations across 23 states position it well for long-term growth. However, potential changes to state and federal policies, including Medicaid funding reforms and potential reductions in reimbursement rates, could impact the company's financials. The recent acquisitions in Indiana and continued M&A pipeline demonstrate the company's commitment to expanding its presence and offsetting potential risks. With a solid financial position, Addus is in a good position to execute additional M&A transactions and achieve its long-term targets.

Bears say

Addus HomeCare is facing multiple challenges including a decrease in hospice revenue due to a decline in patient days and a decrease in home health revenue due to a drop in visits. With a largely saturated market, growth opportunities are limited and competition remains strong, putting pressure on billable rates and revenue. These factors, combined with uncertainty in federal and state regulations, make us bearish on Addus HomeCare's stock.

Addus HomeCare (ADUS) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 7 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Sep 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $127.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $127.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.